Hospital Pharmacist role - Risk analysis for new therapeutics production

3 October 2024

Dr Frederic Marçon -Assistant Professor-CHU Amiens University Hospital- France

The roundtable titled “Risk Analysis Related to the Preparation of New Biotherapies” will focus on the challenges associated with handling emerging therapies such as CAR-T cells, phages, and autologous serum. While these new biotherapies offer promising therapeutic prospects, it is crucial for pharmacists to assess the risks related to their preparation or reconstitution, including cross-contamination, risks to personnel, and environmental impacts. This discussion will bring together experts to explore risk management strategies, biological safety, and best practices to minimize the risks associated with the preparation and administration of these therapies in a hospital setting.

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data